Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

STAT Stitch Deep Dive Podcast Beyond The Bedside

STAT Stitch Deep Dive Podcast Beyond The Bedside artwork

CC Pharm | Diltiazem

Aug 25, 202621 minAudio

Diltiazem (Cardizem) Clinical Summary 1. Action & Class: Benzothiazepine Class IV anti-arrhythmic/anti-anginal. Inhibits calcium influx across myocardial and vascular smooth muscle membranes. This slows AV conduction (prolonging the PR interval), decreases heart rate, and dilates coronary and systemic arteries, reducing afterload and blood pressure. It has fewer negative inotropic effects than verapamil. 2. Therapeutic Uses: Hypertension, stable/variant (Prinzmetal's) angina, and ventricular rate control in atrial fibrillation (AFib), atrial flutter, or PSVT. 3. Administration & Dosages: IV Push: Undiluted, over 2 minutes (0.25 mg/kg bolus; can repeat at 0.35 mg/kg in 15 minutes if needed). Continuous IV: 1 mg/mL dilution, starting at 10 mg/hour; titrate to a maximum of 15 mg/hour (duration >24 hours is not recommended). Oral: IR tablets (30-90 mg, 3-4 times daily). ER formulations (12- or 24-hour) range 120-360 mg/day (maximum 360-540 mg/day depending on formulation). Do not crush or chew ER formulations. 4. Complications & Adverse Effects: Severe: Bradycardia, high-degree AV block, asystole, heart failure, and life-threatening dermatologic reactions like Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN). Common: Peripheral edema (up to 15%), hypotension (4.3%), constipation (3.6%), headache (8.9%), and dizziness (10%). 5. Contraindications & Interactions: Contraindications: Severe heart failure, sick sinus syndrome, 2nd/3rd-degree AV block (without a functioning pacemaker), cardiogenic shock risk, or atrial arrhythmias presenting with pre-excitation (e.g., Wolff-Parkinson-White). Interactions: CYP3A4 substrate and inhibitor; can significantly raise levels of co-administered CYP3A4 substrates. Avoid/limit grapefruit juice (increases drug half-life). Concurrent beta-blockers severely compound the risk of AV block. 6. Nursing Interventions: Monitoring: Monitor ECG (PR interval) and blood pressure/heart rate continuously during IV therapy. Hold Parameters: Hold the dose and immediately notify the provider for severe bradycardia, new-onset heart block, or profound hypotension. Organ Function: Reduce dosage in hepatic impairment (increases half-life and bioavailability); no renal adjustments are required. 7. Client Education: Never split, crush, or chew ER formulations. However, Tiazac capsules can be opened and sprinkled on cool, non-hot applesauce. Change positions slowly to prevent orthostatic hypotension and syncope. Report severe rashes, swelling in lower extremities, or extreme fatigue immediately.

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Transcript

From the show. Tap a time to play from there.

You're in the bay. Once you get over to the bed, we'll give you the story. Everything's going to happen super fast. Welcome to the emergency room. So picture this. You're at the bedside, right? and suddenly the telemetry monitor just

starts blaring. You look up and your patient's heart rate is sitting at like 184 beats per minute. Oh wow. Yeah, that's not good. Right. They are in full blown atrial fibrillation with rapid ventricular response. I mean, their ventricles are firing so fast they barely even have time to fill with blood. Which means stroke volume is just plummeting. Exactly. Cardiac output is completely tanking. You literally have minutes to get this under control before they become hemodynamically unstable. And in that kind of high stakes environment, nursing students or

critical care learners in general, they're expected to have absolute precision. You can't just guess. No, you definitely can't just just throw some random general anti -arrhythmic at them and just hope for the best. Right, you really need to know the exact mechanism of the drug you're pushing, like how the body will react and honestly what alarms are gonna sound next. But the reality is drug monographs are just so... dense. I mean they are this ocean of half -lives and random adverse effects and just endless biochemical jargon. Which is exactly why we're doing this

deep dive today. We are building this strictly for the bedside. Yes, aggressively applying the 80 -20 Pareto principle here. We're focusing on just one vital medication today. Diltiasm. Or you probably know by its brand name, Cardism. Right. We are completely ignoring the fluff. We're focusing exclusively on the highest yield facts from our source material to really build that clinical reasoning and frankly drive... exam performance. Absolutely. So we're going to hit the mechanism, the expected physiological effect, therapeutic uses, adverse effects, and

obviously those priority nursing interventions. Okay. So to really grasp Diltiazem, we need to start at the cellular blueprint, right? Before it even touches an ECG rhythm, what is it actually doing on a microscopic level? Well, Diltiazem is a benzothiazepine calcium channel blocker. So it functions as a class four antiarrhythmic. Okay, class four. Right. And its primary targets are the myocardial cell and the vascular smooth muscle cells. Both of those tissues rely really heavily on this highly selective, slow inward flow of extracellular calcium just to function.

Because calcium is basically the trigger for contraction. Exactly. During the plateau phase of a cellular action potential, the calcium channels open up. Calcium flows into the cell and that influx triggers the actual excitation -contraction coupling. I always think of it like a hydroelectric dam. You know, like the calcium channels are the floodgates. Oh, I like that. Yeah. And when they open, the calcium rushes in like water and it turns these biological turbines that create this strong physical contraction of the muscle fibers. Or, you know, another way to look at

it is like strict bouncers at a nightclub. Right. Diltiasm essentially changes the bouncers rules. Yes. It slows down the influx of those calcium party goers, which just calms the entire club down. That's a great analogy because it physically alters those floodgates. Right. It inhibits that specific inward flow of calcium by literally deforming the channel structure, or it might interfere with the ion control gating mechanisms. The sources even say it might prevent the release of secondary calcium from the sarcoplasmic reticulum

inside the cell. Yeah, the net result is always a massive drop in intracellular calcium. And less calcium means less mechanical force. Exactly. So in the vascular smooth muscle, those cells just lose their grip. The vessels relax. Which means you see this distinct dilation of the coronary arteries feeding the heart, right? And the systemic arteries all over the body. Right. So systemic blood pressure drops. Yeah. Total peripheral resistance decreases, which means a huge decrease in afterload. you know, that vascular resistance

the heart has to pump against. So that handles the plumbing side of things, but diltiasm also fundamentally alters the electrical grid, doesn't it? It does. By restricting calcium in the heart's conduction system, it profoundly slows down the electrical impulses traveling through the AV node. The atrioventricular node. Right. So if you're watching the telemetry monitor, that delay physically manifests as a prolonged PR interval. Okay. But there are plenty of drugs that drop blood pressure and mess with heart rate. If a

provider is looking at the whole class of calcium channel blockers, why are they grabbing Diltiazum specifically? That's the key clinical question. Right, because if we look at its chemical cousins, like Vrapamil or Nifepine... Why is Diltiazem the drug of choice for that AFib patient we talked about earlier? Well, it all comes down to pharmacological balance. I mean, every drug has trade -offs, right? Take verapamil, for example. It has a very strong negative inotropic effect. And anotropy refers to the actual physical squeezing power

of the heart muscle. Exactly. Verapamil weakens that squeeze significantly. So if your patient has, like, borderline heart failure, giving them verapamil could push them straight into cardiogenic shock. Oh, wow. Because their heart just literally stops. pumping hard enough. Right. And then you have nifed pain, which sits on the complete opposite end of the spectrum. It's a highly potent peripheral vasodilator. So it drops the blood pressure too much. It drops it so rapidly that the nervous system basically panics. It triggers reflex tachycardia. The heart suddenly just starts racing to compensate

for that sudden loss of pressure. which is literally the absolute last thing you want for a patient whose heart is already beating at 184 beats per minute. Exactly. So Diltiazem is this perfect Goldilocks drug. It effectively increases coronary blood flow and controls the heart rate by slowing that AV conduction, but it does it without severely tanking the heart's physical pumping power. And without dropping the blood pressure as violently as knife the pain. Right. Plus the clinical data shows it exerts really favorable effects on left

ventricular hypertrophy, the thickening of the heart wall. Oh, that's interesting. Yeah, and unlike some other cardiac meds, it doesn't worsen a patient's insulin resistance or negatively impact their lipid profile. which makes it an absolute powerhouse in critical care. The source material lists its primary indications for managing hypertension, chronic stable angina, and variant angina. Also known as prince metal's angina. Right. But the highest yield application here is definitely the short -term control of ventricular rate in atrial arrhythmias. We're talking AFib,

atrial flutter, and PSVT. Roxas Moll's supraventricular tachycardia. Yeah, the sources actually highlight this really fascinating pediatric study that perfectly illustrates how well it works. Oh yeah, the one with kids from seven months up to 21 years old. That's the one. They require Diltiazum infusions for rapid arrhythmias. And prior to the therapy, their mean ventricular rate was a super dangerous 184 beats per minute. Wow. But by hour six of the continuous infusion, that mean rate had dropped to a highly controlled

108 beats per minute. That's a massive difference. But to get that rapid onset, they must be using the intravenous route, right? Oh, absolutely. When adenosine or vagal maneuvers fail to break a fast rhythm, providers go straight to IV Diltiasm because it literally starts working within minutes. OK, so what's the typical dosing for that? The nurse would administer a 0 .25 milligram per kilogram bolus, and that gets pushed slowly over two full minutes. Two full minutes. Right. And then that's usually followed by a continuous IV infusion running between five and 10 milligrams

per hour. OK, so we associate this drug almost entirely with critical cardiac care, but I have to bring this up because it shocked me. There's a highly unusual off -label use in the text. Oh, the ointment. Yes. Diltiazum formulated as a 2 % ointment and administered intra -anally. At doses of 250 to 700 milligrams every 12 hours. For anal fissures. I mean, seeing a heavy -duty cardiac arrhythmia drug prescribed as an anal ointment is just jarring. It sounds wild, but if you think about the mechanism, it makes perfect

physiological sense. Because it relaxes smooth muscle. Exactly. Yeah. And anal fissure is often caused or worsened by severe spasms of the internal anal sphincter. which is just a ring of smooth muscle. Ah, so when you apply Diltiazum topically, it blocks the calcium channels locally right there. Right. The sphincter muscle relaxes, the spasms stop, and that localized vasodilation dramatically improves blood flow to the torn tissue. so the fissure can finally heal. That is just a brilliant example of taking a systemic mechanism and applying it locally. But okay,

returning to systemic administration, slowing the heart down and relaxing those vessels is great, right up until it's not. Yeah, until because of crisis. When Diltiazum exerts too much of its mechanism, the adverse effects are severe. They're basically direct extensions of its therapeutic intent. Right. You start seeing profound bradycardia, high -degree AV block, and in the worst -case scenarios, a systole or straight -up heart failure. Yeah, and beyond the cardiovascular system, the text actually warns of some rare but really catastrophic

dermatologic reactions. Oh, Stevens -Johnson syndrome, right. Yeah, Stevens -Johnson and toxic epidermal necrolysis, where the patient's skin basically blisters and slubs off. It's incredibly rare, but... Terrifying. Terrifying. And on the more common end of the spectrum? Well, mild to moderate side effects. Up to 15 % of patients will develop peripheral edema. Just because fluid pools in the lower extremities from all that persistent vasodilation. Exactly. And patients also frequently experience hypotension, dizziness, and headaches, mostly because those cerebral

vessels are dilating too. So managing those side effects requires a lot of vigilance. But to me, the true danger zone for a critical care nurse is the drug interactions. Oh, absolutely. Yeah. The plasma's relationship with the liver is incredibly complex. It's metabolized by the CYP3A4 enzyme pathway, right? So it's a substrate. It is, but the source notes that its endomethylated metabolites actually stay behind and inhibit that exact same CYP3A4 enzyme. Wait, so it blocks its own processing pathway. Yes. To visualize this, imagine the

liver's CYP3A4 enzyme is like a specialized processing plant that breaks down hundreds of different meds. Diltiasm goes into the plant to be broken down, but the waste products it leaves behind. The metabolites? Right. Those metabolites actually jam the machinery. The processing plant basically grinds to a halt. Wow. So if you give the patient any other medication that relies on that same plant to be cleared from the body, it won't get processed. Exactly. It just backs up into the bloodstream and rapidly reaches toxic levels. But the single most dangerous interaction, the

one that is guaranteed to be on every pharmacology exam, is giving Diltiasm to a patient who is concurrently receiving beta blockers. Oh yeah, that is a massive red flag. Because if we look at the heart's electrical system like a car, the SA node is the engine, the AV node is the brake pedal. Diltiasm physically presses down on that AV node brake pedal to slow everything down. And... Beta blockers also suppress AV node conduction. They're pressing on the exact same brake pedal just through a different chemical mechanism. So mixing the two intravenously is

literally the equivalent of two drivers violently slamming their feet onto the brake pedal at the exact same time. Right. You completely stall the electrical engine. The synergistic effect can induce severe second or third degree heart block. You're completely severing the electrical communication between the top and bottom of the heart. which leads us directly into our priority nursing interventions. So your primary assessment parameters have to be continuous ECG monitoring to watch for that AV block and really frequent blood pressure checks for catastrophic hypertension.

The absolute key nursing pearl here is knowing exactly when to hold the medication. Right. If the patient is hypotensive, if they're profoundly bradycardic, or if the monitor shows any new signs of heart block, you hold the drug and notify the provider immediately. But what happens if they do crash? Like, what if the heart rate drops to 30 beats per minute and their pressure just bottoms out because the infusion ran too fast? What's the antidote we pull from the crash cart? Okay, so the source material is explicitly clear

on this. There is no specific antidote or reversal agent listed for Diltiazum. Wait, really? No magic bullet at all? Nope. You cannot just push a syringe to instantly undo the calcium channel blockade. That significantly raises the stakes at the bedside. It means our nursing care has to be entirely focused on strict prevention and absolute adherence to those titration limits. Definitely. For a continuous IV infusion, the absolute maximum rate is 15 milligrams per hour. And even more importantly, you must never infuse

it continuously for longer than 24 hours. The 24 -hour limit is because of how those metabolites accumulate, right? Exactly. As the drip runs continuously, active metabolites begin to build up in the patient's tissues. If you run it past that 24 -hour mark, the drug's half -life becomes wildly unpredictable. So if you turn the IB pump off, they're still in danger? Yeah, the accumulated metabolites will continue to suppress their heart rate and blood pressure for an extended... really dangerous period. An organ function plays a huge role in how long the drug lingers, too. Because

the liver is the primary processing plant, any degree of hepatic impairment significantly increases both the drug's half -life and its bioavailability. Right. A liver patient will process the drug much slower, so they require a mandatory dose reduction to avoid toxicity. But what about the kidneys? Well, because the kidneys really only filter out the already deactivated waste, renal impairment requires no dosage adjustment whatsoever. Good to know. Okay, so once the patient is stabilized and we're taking them off the IV drip, transitioning

them to oral medication introduces a whole new set of challenges. It really does, mainly because diltiasm undergoes extensive first -pass metabolism. Right, so when a patient swallows a pill, it gets absorbed through the gut and travels straight to the liver via the portal vein. And the liver just shreds it. It breaks down a massive portion of the drug before it ever even reaches the systemic blood supply. That first pass effect drops the oral bioavailability down to roughly 40 to 60 percent. which is why a patient might be perfectly controlled on a tiny little IV dose, but then

require a surprisingly massive oral dose to get the exact same physiological effect. And the oral formulations themselves are basically an alphabet soup. Cardisome CD, LA, SR, Dilacor, XR. Yeah, those are all extended release capsules designed to slowly leak the medication into the system over like... 12 to 24 hours. And there is a universal nursing rule for these, right? You absolutely cannot crush, cut, or chew them. Never. Destroying the physical matrix of an extended release capsule defeats the time release mechanism

entirely. Because instead of a slow 24 -hour drip of medication, you're just dumping a massive, potentially lethal dose of Diltiazem into their bloodstream all at once. Exactly. You'd induce profound pharmacological shock. But there is one very specific nursing workaround detailed in the text for one particular brand, Tyazak. Oh right, for patients who can't swallow the large capsule. Yeah, you are actually permitted to carefully open the Tyazak capsule and sprinkle the microscopic time release beads onto a spoonful

of applesauce. But the text is super rigid about the conditions. The applesauce must be cool, not warm. Because warmth could actually melt the microscopic enterocodings on those beads, which would destroy the time release safety mechanism. Right. And the mixture has to be swallowed immediately without chewing the beads, followed by a glass of water. Oh, and you can't subdivide the capsule. They have to take the entire thing. Exactly. Now, for pediatric patients who require precise weight -based liquid dosing, standard tablets obviously won't work. So what do they do? The

source outlines this fascinating extemporaneous compounding method. Pharmacists can actually create a 12 milligram per milliliter suspension. Oh, how do they make that? They grind up 16 90 milligram regular release tablets and mix them with a specific liquid base. And if it's refrigerated and stored correctly, that compounded liquid remains pharmacologically stable for up to 60 days. That's super useful. OK, moving to client education. What are we teaching the patient before they go home on this? Two major points stand

out in the text. First is the timing of administration. While many formulations can be taken with or without food, Dilacor XR specifically must be taken on an empty stomach to ensure proper absorption. Okay. Empty stomach for Dilacor XR. And the second point. This is arguably more critical. Dietary restriction. Patients must be warned to completely avoid grapefruit juice. Oh, right. Because grapefruit juice contains compounds that irreversibly inhibit those exact same CYP3A4 liver enzymes we were

talking about earlier. Exactly. If the patient drinks grapefruit juice, they literally paralyze the enzymes responsible for clearing diltiasm. So the drug just builds up in their system? It drastically increases its half -life and puts them at massive risk for toxic bradycardia. All right. We have dissected the cellular mechanisms, the risks, and the admin rules. To lock this in for the bedside and the exam room, Let's use a memory hook. When you think of this drug, just remember the acronym D -I -L -T. Let's break down that D -I -L -T mnemonic. So D stands for dilates. It dilates the coronary and systemic

arteries by blocking calcium in the smooth muscle, dropping blood pressure and afterload. I stands for interacts. It's both a substrate and an inhibitor of the CYP3A4 liver pathway. And it interacts violently with beta blockers to stall the heart's electrical system. L stands for lowers. It lowers the heart rate by suppressing AV node conduction, which again you'll see as a prolonged PR interval on the ECG. And T stands for Tyzac and time. Tyzac is that specific extended release capsule you can sprinkle on cool applesauce, and time

reminds us of the strict 24 -hour maximum time limit on any continuous IV drip to prevent metabolite toxicity. That perfectly encapsulates the clinical profile. So to finish our 80 -20 review, let's just hammer the absolute core facts. If you remember nothing else from this deep dive, here are the highest yield takeaways. Number one, it is a calcium channel blocker that slows AV node conduction. Number two, it is the preferred agent for rapid ventricular rate control in AFib, AFlutter, and PSVT because it doesn't severely depress cardiac

pumping power. Number three, the maximum continuous IV rate is 15 milligrams per hour, never to exceed 24 hours. Number four, there is an extreme risk of heart block. if it's combined with beta blockers. Number five, it inhibits the CYP3A4 enzyme, creating a huge risk for drug toxicity with other meds. Number six, hepatic impairment requires a dose reduction, but renal impairment does not. Number seven, never crush extended release forms, but Tiazact can be sprinkled on cool applesauce.

And number eight, patients must avoid grapefruit juice. That is the elite 20 % of information that is going to govern 80 % of your clinical decision making. But before we conclude, the text leaves us with one final sobering physiological puzzle. Oh yeah. This is a big one. The source material explicitly states, quote, Diltiazem is not significantly removed by hemodialysis. Which is just wild if you think about the implications. Imagine you're at the bedside managing a patient with end stage renal failure. They suddenly go into atrial fibrillation with a rapid ventricular

response. You push IV Diltiazem to control the rate. But what if they become toxic? What if their heart rate plummets to 30 beats per minute and their blood pressure just crashes? We already know there's no antidote. And because the drug molecules bind in a way that prevents them from being filtered by a dialysis machine... You can't just dialyze the toxicity away. You are completely locked in to the pharmacological effects until the liver slowly processes it out on its own. I mean, how does knowing that single fact change

your vigilance, your titration speed, and just your basic respect for the drug the moment you hang that IV bag? It really changes everything. It forces you to respect the cellular chemistry before you ever press start on the IV pump. We started this deep dive talking about how overwhelming pharmacology can be, but when you really understand the mechanism... When you know exactly why the rules exist. Right, the muddy waters just clear up. Thank you for joining us on this deep dive. Take these clinical pearls straight to your next critical care shift, and we will catch you next time.

Open the transcript file

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. CC | PRIMER Emergency Nursing & Disaster Nursing

    Oct 31, 202623 minAudio

    80/20 High-Yield Emergency Nursing Summary 1. Triage & ESI System Goal: Rapidly categorize patient acuity to treat life threats first[1]. ESI-1: Immediate lifesaving intervention (e.g., cardiac arrest, intubated trauma,...

    Credit the people on this episode

  2. CC | Emergency Nursing & Disaster Nursing

    Oct 31, 202655 minAudio

    80/20 High-Yield Emergency Nursing Summary 1. Triage & ESI System Goal: Rapidly categorize patient acuity to treat life threats first[1]. ESI-1: Immediate lifesaving intervention (e.g., cardiac arrest, intubated trauma,...

    Credit the people on this episode

  3. NURSE | The Landscape of The US Healthcare System

    Oct 30, 202646 minAudio

    This episode I go into detail of the current landscape of the US healthcare system and why, you the healthcare practitioner, are under paid and the why your hospital is struggling.

    Credit the people on this episode

  4. NURSE | The Problem With Nurse Residency Programs

    Oct 30, 202621 minAudio

    In this episode I discuss the issues with nurse residency programs

    Credit the people on this episode

  5. NURSE | Peds, E-Bikes, and ATVs

    Oct 28, 202617 minAudio

    This episode details two Pedi Level 1 cases and how important it is for your kids to wear helmets and safety equipment.

    Credit the people on this episode